Dr Alan Smith
Vice-President, Clinical, Regulatory & Operations

4P Therapeutics

Is this your profile?

About

Alan Smith, PhD, is Vice-President, Clinical, Regulatory & Operations at 4P Therapeutics.

Contributions

NOVEL TRANSDERMAL DELIVERY SYSTEMS FOR TREATMENT OF DIABETES

Alan Smith outlines the stages of Type 2 diabetes treatment, progressing to extenatide and insulin injections, and makes the case, using clinical data, for the transdermal route as a viable alternative to injections.

Top

W3 Total Cache is currently running in Pro version Development mode.